Franklin Street Advisors’s Supernus Pharmaceuticals SUPN Stock Holding History

Franklin Street Advisors’s Portfolio SUPN Stock Details SUPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$930K	Hold	20,000	–	–	0.05%	87
2026 Q1	$1.03M	Hold	20,000	–	–	0.06%	82
2025 Q4	$994K	Hold	20,000	–	–	0.06%	83
2025 Q3	$956K	Hold	20,000	–	–	0.06%	79
2025 Q2	$630K	Hold	20,000	–	–	0.04%	100
2025 Q1	$655K	Hold	20,000	–	–	0.05%	101
2024 Q4	$723K	Hold	20,000	–	–	0.05%	97
2024 Q3	$624K	Sell	20,000 -140	-0.7%	-$4.37K	0.04%	96
2024 Q2	$539K	Hold	20,140	–	–	0.04%	101
2024 Q1	$687K	Hold	20,140	–	–	0.05%	89
2023 Q4	$583K	Hold	20,140	–	–	0.05%	92
2023 Q3	$555K	Hold	20,140	–	–	0.05%	93
2023 Q2	$605K	Buy	20,140 +140	+0.7%	+$4.9K	0.05%	93
2023 Q1	$725K	Hold	20,000	–	–	0.07%	83
2022 Q4	$713K	Hold	20,000	–	–	0.07%	87
2022 Q3	$677K	Hold	20,000	–	–	0.07%	92
2022 Q2	$578K	Hold	20,000	–	–	0.05%	96
2022 Q1	$646K	Sell	20,000 -1,145	-5%	-$35.1K	0.05%	97
2021 Q4	$617K	Sell	21,145 -19,000	-47%	-$576K	0.05%	104
2021 Q3	$1.07M	Buy	40,145 +18,000	+81%	+$483K	0.09%	78
2021 Q2	$682K	Sell	22,145 -2,000	-8%	-$61.3K	0.06%	94
2021 Q1	$632K	Hold	24,145	–	–	0.06%	98
2020 Q4	$607K	Hold	24,145	–	–	0.06%	96
2020 Q3	$503K	Sell	24,145 -4,500	-16%	-$102K	0.05%	98
2020 Q2	$680K	Hold	28,645	–	–	0.08%	85
2020 Q1	$515K	Hold	28,645	–	–	0.08%	90
2019 Q4	$679K	Hold	28,645	–	–	0.08%	92
2019 Q3	$787K	Hold	28,645	–	–	0.1%	83
2019 Q2	$948K	Hold	28,645	–	–	0.12%	80
2019 Q1	$1M	Sell	28,645 -55	-0.2%	-$2.05K	0.14%	78
2018 Q4	$953K	Sell	28,700 -500	-2%	-$21.5K	0.15%	80
2018 Q3	$1.47M	Hold	29,200	–	–	0.2%	70
2018 Q2	$1.75M	Hold	29,200	–	–	0.26%	67
2018 Q1	$1.34M	Hold	29,200	–	–	0.2%	72
2017 Q4	$1.16M	Sell	29,200 -200	-0.7%	-$7.9K	0.17%	83
2017 Q3	$1.18M	Hold	29,400	–	–	0.19%	82
2017 Q2	$1.27M	Sell	29,400 -1,600	-5%	-$56.9K	0.22%	78
2017 Q1	$970K	Sell	31,000 -62,000	-67%	-$1.66M	0.17%	87
2016 Q4	$2.35M	Hold	93,000	–	–	0.41%	69
2016 Q3	$2.3M	Sell	93,000 -13,375	-13%	-$303K	0.42%	72
2016 Q2	$2.17M	Sell	106,375 -8,200	-7%	-$145K	0.41%	72
2016 Q1	$1.75M	Sell	114,575 -10,075	-8%	-$131K	0.35%	76
2015 Q4	$1.68M	Sell	124,650 -8,425	-6%	-$130K	0.33%	90
2015 Q3	$1.87M	Sell	133,075 -25,700	-16%	-$478K	0.37%	78
2015 Q2	$2.7M	Buy	158,775 +12,450	+9%	+$177K	0.48%	62
2015 Q1	$1.77M	Sell	146,325 -42,650	-23%	-$403K	0.32%	85
2014 Q4	$1.57M	Sell	188,975 -34,100	-15%	-$287K	0.3%	85
2014 Q3	$1.94M	Buy	223,075 +6,725	+3%	+$60.7K	0.37%	69
2014 Q2	$2.37M	Sell	216,350 -23,550	-10%	-$210K	0.45%	64
2014 Q1	$2.15M	Buy	239,900 +31,450	+15%	+$290K	0.43%	67
2013 Q4	$1.57M	Buy	208,450 +33,250	+19%	+$232K	0.32%	80
2013 Q3	$1.28M	Buy	175,200 +59,700	+52%	+$401K	0.29%	84
2013 Q2	$743K	Buy	+115,500	New	+$680K	0.18%	139

Other funds holding SUPN

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

WCM

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

CNAM

Campbell Newman Asset Management Milwaukee, Wisconsin $1.35B AUM 38.87% 1-Year Est. Return

ETC

Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

SOADOR

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

LSERS

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return

JIR

James Investment Research Alpha, Ohio $984M AUM 36.03% 1-Year Est. Return

Franklin Street Advisors's SUPN Position: Q2 2026 in Review

Franklin Street Advisors held its Supernus Pharmaceuticals (SUPN) position steady in Q2 2026 at 20,000 shares worth $930K. The position accounts for 0.05% of the portfolio, ranked #87.

Franklin Street Advisors first reported a position in SUPN in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.7M in Q2 2015. 58 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.

Franklin Street Advisors held 20,000 shares of Supernus Pharmaceuticals worth $930K as of Q2 2026.
Franklin Street Advisors left its Supernus Pharmaceuticals share count unchanged in Q2 2026.
Supernus Pharmaceuticals made up 0.05% of Franklin Street Advisors's portfolio in Q2 2026, its #87 holding.
Franklin Street Advisors first reported a position in Supernus Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
Franklin Street Advisors's Supernus Pharmaceuticals position peaked at $2.7M in Q2 2015.
58 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.

Based on Franklin Street Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.